1. Home
  2. BIO

as 07-19-2024 4:00pm EST

$
-
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Industrials

Biotechnology: Laboratory Analytical Instruments

Nasdaq

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Founded: 1952 Country:
United States
United States
Employees: N/A City: HERCULES
Market Cap: 8.7B IPO Year: N/A
Target Price: $410.00 AVG Volume (30 days): 311.6K
Analyst Decision: Buy Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -10.69 EPS Growth: N/A
52 Week Low/High: $261.59 - $431.79 Next Earning Date: 08-01-2024
Revenue: $2,605,238,000 Revenue Growth: -6.25%
Revenue Growth (this year): 0.25% Revenue Growth (next year): 5.27%

BIO Daily Stock ML Predictions

Share on Social Networks: